Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial. (2023)
Attributed to:
Developing Existing Healthcare Technologies to Deliver More Affordable and Effective Cancer Care
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1148/radiol.220762
PubMed Identifier: 36511804
Publication URI: http://europepmc.org/abstract/MED/36511804
Type: Journal Article/Review
Volume: 307
Parent Publication: Radiology
Issue: 1
ISSN: 0033-8419